Skip to main content
All lobbying filings

RUBICON ADVISORS, LLC

Lobbying for DYNAVAX TECHNOLOGIES · Pharmaceuticals

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $75,000.00 income · posted Jul 19, 2025

Official filing document

 Lobbying activity 1
Pharmacy

Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem